Studio Display XDR’s Medical Imaging Mode, and the FDA Clearance Apple Has Not Confirmed

Apple Unveils New Mac Studio With M5 Max and M5 Ultra, Up to 512GB RAM

Studio Display XDR, at $3,299, is the only standalone display Apple sells with a built-in medical imaging mode. It ships with DICOM presets and a Medical Imaging Calibrator, and at launch in March 2026 Apple stated that FDA clearance for that mode was still pending. Six months later, Apple has not published anything in the material gathered here confirming that clearance has landed, even as iPhone 18 Pro and the rest of Apple’s September lineup have moved well past their own announcements.

Apple Launches New Mac mini With M6 and M5 Pro, Starting at $899
The Mac mini with M6. Studio Display XDR is built for heavier workloads than this machine typically runs. Image: Apple

That makes the calibrator one of the more distinctive things Apple has built into a product this year, alongside everything else Apple announced in 2026, and it is also one of the least-covered.

Key facts

SpecStudio Display XDR
Price$3,299 ($3,199 education)
Panel27-inch, 5120-by-2880, mini-LED backlight
Local dimming zones2,304
BrightnessUp to 1000 nits SDR, 2000 nits peak HDR
Contrast1,000,000 to 1
ColourP3 and Adobe RGB
Refresh rate120Hz, Adaptive Sync 47Hz to 120Hz
Medical modeDICOM presets, Medical Imaging Calibrator; FDA clearance was pending at launch
Macbook
A MacBook, whose 16-inch model is the one Studio Display XDR is rated to fast-charge at up to 140W. Image: Apple

What the medical imaging mode actually is

Apple’s own description covers two pieces: DICOM presets, which follow the imaging standard hospitals and radiology software use, and a Medical Imaging Calibrator, a tool for tuning the display to that standard. Apple has not published, in the material reviewed for this article, the specific luminance targets, grayscale standard or calibration workflow the tool follows, so those details should be treated as unpublished rather than assumed from general DICOM practice.

Don’t miss the best of The Mac Observer

Set us as a preferred source and our Apple reporting ranks higher in your Google Search results and Discover feed — one tap, no account changes.

Or get it by email
Apple logo
Apple's logo, used here in place of product photography Apple has not supplied for this batch. Image: Apple

Why Apple flagged clearance as pending in the first place

Displaying diagnostic medical images is regulated in the United States, and Apple’s own March 2026 announcement noted FDA clearance as pending rather than complete at that point. That is Apple choosing to disclose a regulatory gap on its own product page rather than glossing over it, which is unusual enough to be worth noting on its own. It also means that, strictly, the medical imaging mode was shipping ahead of the regulatory clearance that would make it fit for the clinical use its own presets are named for.

What has changed since March, and what has not

Nothing in the material gathered for this article shows Apple issuing a follow-up statement on the clearance either way. Apple has not published a cleared date, a rejection, or an updated statement narrowing the scope of the medical imaging mode. Given that six months, or roughly 26 weeks, have passed since the March 11 availability date, the honest position is that this is an open question Apple’s own pages have not answered, not a settled one.

The rest of Studio Display XDR, in brief

Outside the medical mode, Studio Display XDR is Apple’s high end pro monitor: a mini-LED panel with 2,304 local dimming zones, up to 2000 nits of peak HDR brightness, a 1,000,000-to-1 contrast ratio, and a 120Hz refresh rate with Adaptive Sync down to 47Hz. It carries two Thunderbolt 5 and two USB-C ports, charges a connected laptop at up to 140W, and functions as a Thunderbolt hub on its own. Apple’s Mac Studio material states that a Mac Studio configured with M5 Max, part of the same 2026 chip generation as A20 Pro in iPhone 18 Pro, can drive up to four Studio Display XDR units at once, running at 5K resolution and 120Hz across all four.

What Apple has not said

Apple has not confirmed FDA clearance for the Medical Imaging Calibrator since flagging it as pending in March. It has not published the calibration targets the tool follows, has not said whether any healthcare customer has deployed the display clinically, and has not stated whether a clearance delay would ever affect the display’s availability for non-clinical buyers, who make up the more likely audience for a $3,299 monitor. It has also not linked the calibrator to macOS 27, arriving Monday, September 14, in any way.

As of September 12, the clearance question remains open on Apple’s own record, and it is worth checking again once Apple next updates its Studio Display XDR support pages.